SeaSpine spin-off effective July 1, Integra board of directors approve — 8 key notes

Integra LifeSciences’ board of directors approved the separation of SeaSpine Holdings from Integra.

Advertisement

Here are eight things to know about the move:

 

1. The board of directors approved the separation in a tax-free dividend involving the distribution of all outstanding SeaSpine common stock shares to Integra common stock holders.

 

2. The SeaSpine common stock will be distributed on July 1 to Integra stockholders of record as of 5 pm EST on June 19, 2015.

 

3. The Integra stockholders will receive one SeaSpine common stock share for every three shares of Integra common stock they hold.

 

4. When the distribution is complete, SeaSpine will immediately become an independent publicly-traded company.

 

5. SeaSpine’s first day of public trading will begin on July 2 and the company will be listed on the Nasdaq Global Market under “SPNE.”

 

6. SeaSpine will own and operate Integra’s orthobiologics and spinal fusion hardware business.

 

7. Neither SeaSpine nor Integra will have ownership interest in the other company.

 

8. Piper Jaffray is acting as financial advisor to Integra in connection with the SeaSpine spin-off.

 

More articles on orthopedic devices:
10 trends to note in the knee implant market
8 trends in the North American neurosurgery market
5 predictions about the 2012-2018 bio-implant market

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.